Skip to content

Getting Vertex Pharmaceuticals’ Orphan Drug Kalydeco (Ivacaftor) To The UK Continues (November 7, 2012 Update)

November 8, 2012

       The Cystic Fibrosis (CF) Trust in the UK updates on November 7, 2012, the status of bringing Vertex Pharmaceuticals’ orphan drug Kalydeco (Ivacaftor) to the UK. The Clinical Priorities Advisory Group (CPAG) issues a statement describing discussions with Vertex Pharmaceutical as “very positive”. By the middle of November 2012, CPAG expects to make a recommendation, with final NHS commissioners making a decision in December 2012. 

References 

CPAG November 7, 2012 Statement  

Cystic Fibrosis (CF) Trust’s Campaign for Kalydeco iPetition  

Cystic Fibrosis (CF) Trust November 7, 2012 Kalydeco Update   

Irish Examiner November 8, 2012 article.   

Copyright © 2012-2013, Orphan Druganaut Blog.  All rights reserved.

Advertisements
Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: